Cardiovascular mortality in people with cancer compared to the general population: A systematic review and meta‐analysis DOI Creative Commons
Huah Shin Ng, Xingqiong Meng, Tania Marin

et al.

Cancer Medicine, Journal Year: 2024, Volume and Issue: 13(15)

Published: Aug. 1, 2024

Abstract Background Cardiovascular disease (CVD) is the leading cause of non‐cancer death in cancer survivors, but risk CVD varies between cancers. Objectives To synthesise available evidence on patterns and magnitude mortality risk. Methods A systematic search Medline (OVID), CINAHL Scopus databases from 01‐January‐2000 to 16‐July‐2023 studies people with cancer, reporting population compared a reference (e.g. general population) as standardised ratios (SMR). Meta‐analysis SMRs across types were pooled using random‐effects model allow for heterogeneity true effect size studies. Results We identified 136 16 countries. Sample sizes ranged 157 7,529,481. The majority ( n = 98; 72%) conducted United States, followed by Europe 22; 16%). most common cancers studied gastrointestinal 34 studies), haematological 31) breast 29). total 876 extracted diverse conditions. Of those, (535; 61%) indicated an increased (SMR >1), 109 (12%) lower <1) 232 (27%) equivalent (95% CI SMR included 1) population. meta‐analysis all reported showed 1.55, 95% 1.40–1.72) survivors varied conditions 1.36 1.29–1.44) heart diseases 1.56 1.39–1.76) cerebrovascular diseases. types, ranging 1.14 1.04–1.25) testicular/germ cell tumours 2.82 2.20–3.63) brain/central nervous system tumours. Conclusions Cancer are at premature population, type CVD. Future research should focus understanding mechanisms behind develop appropriate interventions.

Language: Английский

Investigating modifiable risk factors associated with ideal cardiovascular health among cancer survivors: a scoping review DOI Creative Commons
Wing Lam Tock, Yujia Tang, Lise Gauvin

et al.

Cardio-Oncology, Journal Year: 2025, Volume and Issue: 11(1)

Published: March 31, 2025

Abstract Background Cancer survivors are at higher risk of developing cardiovascular diseases and face worse morbidity mortality outcomes than the general population. The American Heart Association (AHA) introduced Life’s Essential 8 framework, encompassing eight modifiable factors lifestyle behaviors for maintaining ideal health (CVH). Although this framework is well-established predicting CVH in population, studies on its association with among cancer remain scattered across literature. Objective This review maps existing literature surrounding factors, behaviors, CVH, to take stock what known, identify methodological strengths weaknesses, propose promising research directions. Methods A scoping was conducted examining different dimensions adult survivors. Measurement methods metrics, determinants associated were examined. Results Twenty-two articles met eligibility criteria. Of which, 82% ( n = 18) published or after 2020. Fourteen (about 64%) followed AHA’s conceptualize CVH. Higher scores linked better associations noted social inequalities neighborhood environmental underscoring complexity Conclusions Research appears have accelerated recent years, yet many gaps orient clinical public practice. Promising directions include expanding investigations into pre-diagnosis addressing disparities diverse populations, conducting longitudinal clarify causal pathways between treatments, outcomes.

Language: Английский

Citations

0

Cardiovascular mortality in people with cancer compared to the general population: A systematic review and meta‐analysis DOI Creative Commons
Huah Shin Ng, Xingqiong Meng, Tania Marin

et al.

Cancer Medicine, Journal Year: 2024, Volume and Issue: 13(15)

Published: Aug. 1, 2024

Abstract Background Cardiovascular disease (CVD) is the leading cause of non‐cancer death in cancer survivors, but risk CVD varies between cancers. Objectives To synthesise available evidence on patterns and magnitude mortality risk. Methods A systematic search Medline (OVID), CINAHL Scopus databases from 01‐January‐2000 to 16‐July‐2023 studies people with cancer, reporting population compared a reference (e.g. general population) as standardised ratios (SMR). Meta‐analysis SMRs across types were pooled using random‐effects model allow for heterogeneity true effect size studies. Results We identified 136 16 countries. Sample sizes ranged 157 7,529,481. The majority ( n = 98; 72%) conducted United States, followed by Europe 22; 16%). most common cancers studied gastrointestinal 34 studies), haematological 31) breast 29). total 876 extracted diverse conditions. Of those, (535; 61%) indicated an increased (SMR >1), 109 (12%) lower <1) 232 (27%) equivalent (95% CI SMR included 1) population. meta‐analysis all reported showed 1.55, 95% 1.40–1.72) survivors varied conditions 1.36 1.29–1.44) heart diseases 1.56 1.39–1.76) cerebrovascular diseases. types, ranging 1.14 1.04–1.25) testicular/germ cell tumours 2.82 2.20–3.63) brain/central nervous system tumours. Conclusions Cancer are at premature population, type CVD. Future research should focus understanding mechanisms behind develop appropriate interventions.

Language: Английский

Citations

2